Shunkichi Ikegaki

Shunkichi Ikegaki

Auto-generated profile, based on publicly available information

Shunkichi Ikegaki

Division of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
SIShunkichi Ikegaki
Shunkichi Ikegaki
GOGoh Ohji
Goh Ohji
KEKei Furui Ebisawa
Kei Furui Ebisawa
MTMitsutaka Tsujimura
Mitsutaka Tsujimura
KOKenichiro Ohnuma
Kenichiro Ohnuma
KIKentaro Iwata
Kentaro Iwata
We retrospectively reviewed patients with Corynebacterium striatum bacteremia treated with daptomycin. All 11 isolates were initially susceptible to daptomycin, but the emergence of daptomycin nonsusceptibility during treatment and clinical failure occurred in 36% and 45% of patients, respectively.

17 February 2026 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
SIShunkichi Ikegaki
Shunkichi Ikegaki
YNYuka Nagatsuka
Yuka Nagatsuka
SBSayaka Ban
Sayaka Ban
DKDaiki Kano
Daiki Kano
GOGoh Ohji
Goh Ohji
YSYuhki Sato
Yuhki Sato

11 December 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
HNHana Niino
Hana Niino
SIShunkichi Ikegaki
Shunkichi Ikegaki
KIKentaro Iwata
Kentaro Iwata

1 October 2017 in The Egyptian Journal of Chest Diseases and Tuberculosis
Verified
Journal Article
Open access
TTTomoyasu Takemura
Tomoyasu Takemura
SIShunkichi Ikegaki
Shunkichi Ikegaki
ESEmiko Saito
Emiko Saito
HMHirotaka Matsumoto
Hirotaka Matsumoto
MSMariko Shinomiya
Mariko Shinomiya
Yuki KataokaYuki Kataoka
Yuki Kataoka
Background: Malignant pleural effusion reduces cancer patients’ quality of life. Some experts have suggested that chest tubes should be directed posteriorly during pleurodesis. We conducted this study to clarify whether a posteriorly positioned chest tube has a better success rate than does an interlobular or anterior one. Methods: We performed a retrospective chart review of patients undergoing pleurodesis between April 2011 and September 2016, and 86 patients were enrolled and divided into two groups based on the chest tube position: posterior (group 1) and others [interlobular and anterior (group 2)]. The primary endpoint was the success rate of pleurodesis, and the secondary endpoint was the complication rate (pain and fever). P < 0.05 was considered to be significant. Results: In total, 66, 20 patients were included in groups 1 and 2, respectively. Complete and partial success was achieved in 57 (86%) and 15 (75%) patients in groups 1 and 2, respectively. The success rates were similar in all groups (p = 0.39). Complications were observed in 51 (77%) and 16 (80%) patients in groups 1 and 2, respectively (p = 0.99). Between the two groups, there was no statistically significant difference in terms of age and sex. Conclusions: In malignant pleural effusion, the success rates of pleurodesis may be similar regardless of the position of the tube. However, this is a retrospective study with insufficient participants. Hence, further investigation is required